Giuseppe Derosa Selected Research

Glycated Hemoglobin (Glycosylated Hemoglobin)

1/2021	Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers.
9/2020	Abscisic Acid Treatment in Patients with Prediabetes.
1/2020	Change of some oxidative stress parameters after supplementation with whey protein isolate in patients with type 2 diabetes.
1/2019	Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients.
1/2018	Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes.
1/2017	Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes.
4/2015	Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus.
7/2014	Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
4/2014	Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluation.
8/2013	Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Derosa Research Topics

Disease

69	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
68	Insulin Resistance 01/2022 - 08/2004
42	Body Weight (Weight, Body) 05/2021 - 04/2003
30	Hypertension (High Blood Pressure) 03/2021 - 02/2003
21	Inflammation (Inflammations) 01/2021 - 04/2006
18	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 05/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 10/2004
11	Hypercholesterolemia 11/2020 - 04/2003
10	Essential Hypertension 02/2017 - 07/2003
9	Overweight 05/2016 - 08/2007
8	Obesity 01/2018 - 08/2004
8	Atherosclerosis 01/2018 - 04/2009
7	Hyperlipidemias (Hyperlipidemia) 01/2022 - 10/2004
7	Glucose Intolerance 09/2020 - 01/2006
6	Dyslipidemias (Dyslipidemia) 11/2020 - 04/2009
6	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 06/2010
5	COVID-19 03/2021 - 01/2021
5	Coronary Disease (Coronary Heart Disease) 11/2020 - 02/2003
5	Acute Coronary Syndrome 01/2017 - 01/2007
5	Weight Loss (Weight Reduction) 01/2017 - 05/2008
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2015 - 04/2009
5	Atrial Fibrillation 06/2014 - 03/2008
4	Diabetes Mellitus 05/2021 - 07/2003
4	Neoplasms (Cancer) 01/2018 - 01/2016
3	Fibrosis (Cirrhosis) 10/2020 - 03/2012
3	Heart Failure 01/2019 - 10/2010
3	Metabolic Diseases (Metabolic Disease) 12/2017 - 05/2003
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2016 - 01/2004

Drug/Important Bio-Agent (IBA)

52	LipidsIBA 01/2021 - 04/2003
48	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2003
43	Insulin (Novolin)FDA Link 03/2022 - 08/2004
29	Metformin (Glucophage)FDA LinkGeneric 05/2021 - 06/2003
25	C-Reactive ProteinIBA 09/2020 - 04/2006
22	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 08/2004
21	Amlodipine (Norvasc)FDA LinkGeneric 07/2015 - 12/2002
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2006
17	Pioglitazone (Actos)FDA Link 01/2018 - 05/2004
16	oxidized low density lipoproteinIBA 01/2022 - 04/2003
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
16	ResistinIBA 01/2021 - 05/2008
15	Rosiglitazone (Avandia)FDA Link 01/2018 - 05/2004
13	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 05/2005
13	AdiponectinIBA 01/2020 - 05/2008
12	CholesterolIBA 11/2020 - 04/2003
12	HDL CholesterolIBA 11/2020 - 04/2003
11	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2003
11	LDL CholesterolIBA 11/2020 - 04/2003
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 10/2004
10	Nicotinamide PhosphoribosyltransferaseIBA 01/2021 - 01/2010
10	olmesartanIBA 01/2014 - 01/2008
9	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2005
9	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 09/2007
9	Acarbose FDA LinkGeneric 01/2017 - 01/2006
9	Vitamin A (Retinol)FDA LinkGeneric 05/2015 - 01/2010
9	glimepiride (Amarel)FDA LinkGeneric 07/2014 - 02/2003
9	Telmisartan (Micardis)FDA Link 06/2012 - 07/2004
9	Antihypertensive Agents (Antihypertensives)IBA 01/2011 - 07/2003
8	Sitagliptin Phosphate (Januvia)FDA Link 10/2019 - 06/2010
8	Valsartan (Vals)FDA Link 01/2012 - 03/2005
7	Pharmaceutical PreparationsIBA 06/2015 - 10/2004
7	Glucagon (Glukagon)FDA Link 07/2014 - 06/2012
7	LeptinIBA 10/2011 - 03/2005
6	Lipoprotein(a)IBA 03/2022 - 02/2003
6	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2006
6	VildagliptinIBA 01/2017 - 06/2012
6	sibutramine (Meridia)FDA Link 01/2017 - 11/2008
6	Carnitine (L-Carnitine)FDA LinkGeneric 05/2015 - 05/2003
6	ProinsulinIBA 07/2014 - 06/2010
6	Ramipril (Altace)FDA LinkGeneric 12/2013 - 09/2008
6	ThiazolidinedionesIBA 06/2012 - 02/2008
6	Irbesartan FDA LinkGeneric 12/2011 - 06/2005
5	AdipokinesIBA 01/2021 - 12/2012
5	CanrenoneIBA 01/2019 - 11/2013
5	Metalloproteases (Metalloproteinases)IBA 02/2015 - 01/2007
5	Orlistat (Xenical)FDA Link 05/2012 - 04/2003
5	candesartanIBA 12/2011 - 07/2003
5	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2011 - 01/2004
4	QuercetinIBA 03/2021 - 01/2021
4	Plasminogen Activator Inhibitor 1IBA 01/2021 - 05/2005
4	CurcuminIBA 03/2018 - 01/2016
4	AldosteroneIBA 01/2018 - 03/2010
4	red yeast riceIBA 01/2017 - 08/2013
4	BerberineIBA 01/2017 - 01/2012
4	Losartan (Cozaar)FDA LinkGeneric 04/2016 - 04/2009
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2015 - 07/2003
4	C-PeptideIBA 08/2013 - 06/2012
4	Arginine (L-Arginine)FDA Link 08/2013 - 06/2012
3	Biological ProductsIBA 01/2022 - 01/2011
3	ertugliflozinIBA 05/2021 - 01/2017
3	Antiviral Agents (Antivirals)IBA 03/2021 - 01/2021
3	HomocysteineIBA 01/2021 - 02/2003
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 02/2003
3	PolyphenolsIBA 03/2018 - 12/2017
3	Angiotensin Receptor AntagonistsIBA 01/2018 - 04/2007
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 04/2009
3	Blood Glucose (Blood Sugar)IBA 01/2017 - 01/2008
3	Atorvastatin (Lipitor)FDA Link 01/2017 - 09/2004

Therapy/Procedure

51	Therapeutics 01/2022 - 05/2003
36	Glycemic Control 01/2018 - 02/2003
3	Drug Therapy (Chemotherapy) 11/2020 - 06/2003